Blood Microbiome Reveals the Impact of Lactobacillus on the Efficacy of Immunotherapy in Gastrointestinal Cancer
Abstract Immunotherapy has revolutionized the treatment of gastrointestinal (GI) cancers, but reliable biomarkers for predicting treatment efficacy remain limited. In this study, we explored the potential of blood microbiome and specific microbial taxa as novel biomarkers for predicting the efficacy...
Saved in:
| Main Authors: | Ya‐Shang Zheng, Wu‐Hao Lin, Jun‐Quan Chen, Xiao‐Li Wei, Jia‐Qian Huang, Yu‐Hong Xu, Meng Yang, Qi‐Hua Zhang, Zhi‐Jun Zuo, Zhao‐Ying Yang, Pan Zhang, Nga Ki HONG, Lu‐Xuan Liu, Zhao‐Lei Zeng, Rui‐Hua Xu, Hui‐Yan Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | MedComm |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.70316 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nutritional status, immunonutrition, and gut microbiome: a coming of age for immunotherapy?
by: Elisa Mattavelli, et al.
Published: (2025-08-01) -
Unveiling the Kadaknath Gut Microbiome: Early Growth Phase Spatiotemporal Diversity
by: Amruta Nair, et al.
Published: (2025-02-01) -
Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence
by: Csenge Somodi, et al.
Published: (2025-07-01) -
Biological properties of lactobacillus
by: N. A. Glushanova
Published: (2003-12-01) -
Lactobacillus plantarum liver abscess following ERCP: a case report and review
by: Wenjing Ren, et al.
Published: (2025-05-01)